DiagnosingAIP.com provides information concerning the diagnosis of Acute Intermittent Porphyria (AIP). The content on this website is intended for U.S. doctors and healthcare professionals only.

Click to close this window and enter DiagnosingAIP.com

You are about to leave the DIAGNOSING ACUTE INTERMITTENT PORPHYRIA (AIP) website and enter a website operated by an independent third party. The links to third-party websites contained on DiagnosingAIP.com are provided solely for your convenience. Lundbeck does not control the opinions, claims or comments contained on any third-party website linked to DiagnosingAIP.com, and your activities at those websites will be governed by the policies and practices of those third parties.

Challenging diagnosis, critical determination1

Acute Intermittent Porphyria (AIP) is a rare inherited disorder caused by a partial deficiency of a specific enzyme (porphobilinogen deaminase) in the heme biosynthetic pathway. The wide range of signs and symptoms associated with an attack of AIP may also occur with more common conditions. As a result, patients with AIP may not be readily diagnosed.

Correctly and quickly diagnosing AIP is important for long-term management. Patients with untreated attacks face a risk of permanent neuronal damage and development of severe or chronic neuropathic symptoms. Accurate diagnosis is also needed to educate patients on ways to potentially limit future attacks. Testing is the only way to confirm a diagnosis of Acute Intermittent Porphyria.

  1. Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005; 142:439-50.